A5025810861- Adrenal and Paraganglionic Tumors
- Glioma Diagnosis and Treatment
- Hormonal Regulation and Hypertension
- Parathyroid Disorders and Treatments
- Cancer, Hypoxia, and Metabolism
- Pituitary Gland Disorders and Treatments
- BRCA gene mutations in cancer
- Thyroid Cancer Diagnosis and Treatment
- Thyroid and Parathyroid Surgery
- Multiple and Secondary Primary Cancers
- Genetic Syndromes and Imprinting
- Medical Imaging and Pathology Studies
- Magnesium in Health and Disease
- Meta-analysis and systematic reviews
- Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Apelin-related biomedical research
Hospital of the University of Pennsylvania
2023-2024
University of Pennsylvania Health System
2023-2024
University of Pennsylvania
2024
Large tumor size is associated with poorer outcomes in well-differentiated thyroid cancer, yet it remains unclear whether >4 cm alone confers increased risk, independent of other markers aggressive disease. The goal this study was to assess the relationship between size, high-risk histopathological features, and survival cancer evaluate significance 4 as a cutoff for management decisions.
Abstract Purpose Secondary hyperparathyroidism (SHPT) frequently affects patients with end-stage renal disease. Hungry bone syndrome (HBS) is a common complication among who undergo parathyroidectomy for SHPT and may cause prolonged hospitalization or require intensive care. The objective of this study to develop scoring system stratify according their risk developing HBS. Methods A retrospective cohort was performed using the US Renal Data System (2010-2021). Univariable multivariable...
Metastasectomy is a useful adjunct in the management of metastatic cancer. Widespread adoption novel targeted and immunotherapies has improved survival profiles multiple malignancies, which potentially altered role metastasectomy. This study aimed to characterize trends metastasectomy across five primary cancers eligible for these therapies.